Cargando…
Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation
BACKGROUND: Ex-vivo lung perfusion (EVLP) is an innovative platform for assessing donor lungs in the pre-transplant window. In this study, we demonstrate an extension of its utility by administering the anti-CD20 monoclonal antibody, Rituximab, during EVLP. We hypothesized that this would lead to ta...
Autores principales: | Ku, Terrance J.Y., Ribeiro, Rafaela V.P., Ferreira, Victor H., Galasso, Marcos, Keshavjee, Shaf, Kumar, Deepali, Cypel, Marcelo, Humar, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501077/ https://www.ncbi.nlm.nih.gov/pubmed/32950000 http://dx.doi.org/10.1016/j.ebiom.2020.102994 |
Ejemplares similares
-
Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion
por: Ribeiro, Rafaela V.P., et al.
Publicado: (2023) -
Ex vivo lung perfusion
por: Watanabe, Tatsuaki, et al.
Publicado: (2021) -
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
por: Galasso, Marcos, et al.
Publicado: (2019) -
Increased Arginase Expression and Decreased Nitric Oxide in Pig Donor Lungs after Normothermic Ex Vivo Lung Perfusion
por: Tavasoli, Farshad, et al.
Publicado: (2020) -
When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)